What Happens if VMAT2 is Inhibited? Unpacking the Pharmacological Effects
•
2 min read
Pharmacological inhibition of the vesicular monoamine transporter 2 (VMAT2) has been shown to cause depressive-like symptoms in humans, a finding that helped establish the monoamine-deficiency hypothesis of depression. Today, understanding **what happens if VMAT2 is inhibited** is crucial for treating specific neurological disorders by regulating neurotransmitter levels in the brain.
